zsp1273
Small moleculeexperimental
Clinical trial activity
14 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Sep 20, 2018 (NCT03679143)
Timeline
Indications
Mechanism of action
- Polymerase basic protein 2INHIBITOR
PB2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07229807 | Phase 3 | Nov 30, 2025 | Guangdong Raynovent Biotech Co., Ltd |
| NCT07229820 | Phase 3 | Nov 8, 2025 | Guangdong Raynovent Biotech Co., Ltd |
| NCT06656026 | Phase 2 | Nov 30, 2024 | Guangdong Raynovent Biotech Co., Ltd |
| NCT06248567 | Phase 1 | Jan 15, 2024 | Guangdong Raynovent Biotech Co., Ltd |
| NCT06164431 | Phase 1 | Nov 23, 2023 | Guangdong Raynovent Biotech Co., Ltd |
| NCT06157450 | Phase 1 | Oct 11, 2023 | Guangdong Raynovent Biotech Co., Ltd |
| NCT05954624 | Phase 1 | Jul 10, 2023 | Guangdong Raynovent Biotech Co., Ltd |
| NCT05942365 | Phase 1 | Jun 25, 2023 | Guangdong Raynovent Biotech Co., Ltd |
| NCT05856513 | Phase 1 | Jun 15, 2023 | Guangdong Raynovent Biotech Co., Ltd |
| NCT05873426 | Phase 1 | Mar 25, 2023 | Guangdong Raynovent Biotech Co., Ltd |
| NCT04683406 | Phase 3 | Dec 31, 2020 | Guangdong Raynovent Biotech Co., Ltd |
| NCT05108051 | Phase 1 | Nov 19, 2020 | Guangdong Raynovent Biotech Co., Ltd |
| NCT04024137 | Phase 2 | Sep 30, 2019 | Guangdong Raynovent Biotech Co., Ltd |
| NCT03679143 | Phase 1 | Sep 20, 2018 | Guangdong Zhongsheng Pharmaceutical Co., Ltd., Jilin University |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangdong Raynovent Biotech Co., Ltd | For profit | 13 | 13 | 3 | 2019 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd. | For profit | 1 | 1 | 1 | 2018 |
| Jilin University | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1